|Abacavir - Coronary Disease
Apr 18, 2008
Is there there any connection between Abacavir and Coronary disease? And if so what advice is the manufacturer currently offering?
Response from Dr. Henry
Recent data from the DAD study noted an increased risk for a heart attack in patients that were taking abacavir within the preceding 6 months. The overall risk for a heart attack was small and concentrated among persons at high risk for a heart attack. Increased risk was also seen (to a lesser degree) for patients taking ddI or 3TC. No comparative data was available for patients taking tenofovir which usually would be the preferred alternative drug to abacavir. Also, for little of the population was HLA B5701 testing done which is now recommended before starting abacavir. Focusing on standard risk factors for heart attack remains a high priority while considering switching off abacavir is something to consider perhaps in patients with persistent very high risk for a heart attack. Overall data remains very limited and preliminary so it seems premature to broadly switch off abacavir until more relevant data is available. KH
Interaction between HIV medication and Viagra
- What Happens If You Have Gonorrhea For A Year Without Treatment?
- What Does A Herpes Bump Look Like?
- What Are The Chances Of Getting Herpes When No Outbreaks?
- What Antibiotics Do For Peoples With Herpes?
- Risk Using No Condom When One Partner Has Herpes But Not On An Outbreak
- Risks Of Unprotected Sex With Inactive Herpes
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.